Texas Yale Capital Corp. Alector, Inc. Transaction History
Texas Yale Capital Corp.
- $2.47 Billion
- Q4 2024
A detailed history of Texas Yale Capital Corp. transactions in Alector, Inc. stock. As of the latest transaction made, Texas Yale Capital Corp. holds 10,000 shares of ALEC stock, worth $14,400. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,000Holding current value
$14,400% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding ALEC
# of Institutions
155Shares Held
55MCall Options Held
39.7KPut Options Held
51K-
Ra Capital Management, L.P. Boston, MA9.7MShares$14 Million0.3% of portfolio
-
Black Rock Inc. New York, NY9.1MShares$13.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.62MShares$8.09 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.91MShares$2.76 Million0.0% of portfolio
-
State Street Corp Boston, MA1.85MShares$2.66 Million0.0% of portfolio
About Alector, Inc.
- Ticker ALEC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 82,563,904
- Market Cap $119M
- Description
- Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...